BR112018011504A2 - microcápsulas de trombina - Google Patents

microcápsulas de trombina

Info

Publication number
BR112018011504A2
BR112018011504A2 BR112018011504A BR112018011504A BR112018011504A2 BR 112018011504 A2 BR112018011504 A2 BR 112018011504A2 BR 112018011504 A BR112018011504 A BR 112018011504A BR 112018011504 A BR112018011504 A BR 112018011504A BR 112018011504 A2 BR112018011504 A2 BR 112018011504A2
Authority
BR
Brazil
Prior art keywords
microcapsules
thrombin
thrombin microcapsules
spray
preparation
Prior art date
Application number
BR112018011504A
Other languages
English (en)
Inventor
Gershonovitch Assaf
Ilan Erez
Kaufman Rivka
Original Assignee
Omrix Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omrix Biopharmaceuticals Ltd filed Critical Omrix Biopharmaceuticals Ltd
Publication of BR112018011504A2 publication Critical patent/BR112018011504A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

a presente invenção refere-se a pós de trombina secos por aspersão que compreendem microcápsulas, métodos de preparação e usos dos mesmos.
BR112018011504A 2015-12-08 2016-12-01 microcápsulas de trombina BR112018011504A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562264432P 2015-12-08 2015-12-08
IL242984A IL242984A0 (en) 2015-12-08 2015-12-08 Thrombin microcapsules, their preparation and how to use them
PCT/IL2016/000024 WO2017098493A1 (en) 2015-12-08 2016-12-01 Thrombin microcapsules

Publications (1)

Publication Number Publication Date
BR112018011504A2 true BR112018011504A2 (pt) 2018-12-04

Family

ID=59012760

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018011504A BR112018011504A2 (pt) 2015-12-08 2016-12-01 microcápsulas de trombina

Country Status (9)

Country Link
EP (1) EP3386487A1 (pt)
JP (1) JP6918799B2 (pt)
KR (1) KR20180091035A (pt)
CN (1) CN108366967B (pt)
AU (1) AU2016367536B2 (pt)
BR (1) BR112018011504A2 (pt)
CA (1) CA3007900A1 (pt)
IL (2) IL242984A0 (pt)
WO (1) WO2017098493A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
EP2825216B1 (en) 2012-06-12 2015-08-19 Ferrosan Medical Devices A/S Dry haemostatic composition
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
WO2016102446A1 (en) 2014-12-24 2016-06-30 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
BR112017027695A2 (pt) 2015-07-03 2018-09-04 Ferrosan Medical Devices As seringa para retenção e mistura de primeira e segunda substâncias
BR112020011034A2 (pt) 2017-12-29 2020-11-17 Baxter International Inc. trombina secada por pulverização e métodos para usar e fabricar trombina secada por pulverização
CA3097819A1 (en) 2018-05-09 2019-11-14 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
IL263679A (en) * 2018-12-12 2019-03-31 Omrix Biopharmaceuticals Ltd Kits, methods, and ingredients for preventing tissue adhesion

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107628D0 (en) 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
ES2131206T3 (es) 1993-08-06 1999-07-16 Opperbas Holding Bv Un metodo de carga elevada de vesiculas con sustancias biopolimeras.
EP0914096B1 (en) * 1996-05-17 2003-08-13 Elan Drug Delivery Limited Microparticles and their use in wound therapy
US6121232A (en) 1997-01-31 2000-09-19 Omrix Biopharmaceuticals Sa Stabilized mixture comprising fibrinogen
EP0856317A1 (en) 1997-01-31 1998-08-05 Omrix Biopharmaceuticals S.A. A stabilized mixture comprising fibrinogen
GB9727102D0 (en) 1997-12-22 1998-02-25 Andaris Ltd Microparticles and their therapeutic use
US6703047B2 (en) 2001-02-02 2004-03-09 Incept Llc Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
CZ20033097A3 (cs) 2001-05-21 2004-06-16 Omrix Biopharmaceuticals S.A. Způsob odstranění plasmin(ogenu) z proteinových roztoků
CA2649081A1 (en) 2006-04-10 2007-10-18 Ethicon, Inc. A reinforced absorbable multilayered hemostatic wound dressing and method of making
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
AU2009236960A1 (en) * 2008-04-16 2009-10-22 The Chemo-Sero-Therapeutic Research Institute Method of producing thrombin-immobilized bioabsorbable sheet preparation
US9827205B2 (en) * 2008-12-12 2017-11-28 Mallinckrodt Pharma Ip Trading D.A.C. Dry powder fibrin sealant
WO2011083154A1 (en) 2010-01-08 2011-07-14 Profibrix Bv Dry powder fibrin sealant
AU2011260260B2 (en) * 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
BR112012030455B1 (pt) * 2010-06-01 2021-08-17 Baxter Healthcare S.A. Processo para fabricar uma composição hemostática seca e estável, recipiente acabado final, e, kit para administrar uma composição hemostática
US9212357B2 (en) * 2012-12-03 2015-12-15 Omrix Biopharmaceuticals Ltd. Thrombin solution and methods of use thereof
CN105188740A (zh) 2013-03-07 2015-12-23 普罗菲布里克有限公司 包含凝血酶和纤维蛋白原的粉末制剂
IL229645A0 (en) * 2013-11-26 2014-03-31 Omrix Biopharmaceuticals Ltd A dry bandage containing thrombin and pectin

Also Published As

Publication number Publication date
KR20180091035A (ko) 2018-08-14
AU2016367536A1 (en) 2018-05-17
IL259185A (en) 2018-07-31
CN108366967B (zh) 2021-03-12
JP6918799B2 (ja) 2021-08-11
JP2019501893A (ja) 2019-01-24
EP3386487A1 (en) 2018-10-17
WO2017098493A1 (en) 2017-06-15
CA3007900A1 (en) 2017-06-15
AU2016367536B2 (en) 2021-12-02
IL242984A0 (en) 2016-02-29
CN108366967A (zh) 2018-08-03
IL259185B (en) 2021-07-29

Similar Documents

Publication Publication Date Title
BR112018011504A2 (pt) microcápsulas de trombina
BR112018073384A2 (pt) polinucleotídeos moduladores
BR112018010211A2 (pt) formulação farmacêutica aquosa compreendendo anticorpo anti-pd-l1 avelumab
CL2019000609A1 (es) Variantes de alfa-glucosidasa ácida y usos de las mismas.
CL2016002569A1 (es) Anticuerpos, composiciones farmacéuticas y usos de los mismos
DK3148578T3 (da) Stabiliserede influenza-hæmagglutininstammeområdetrimerer og anvendelser deraf
BR112016028891A2 (pt) processos de trens de sementes e usos dos mesmos
CL2019000610A1 (es) Variantes de alfa-glucosidasa ácida y usos de las mismas.
BR112017026559A2 (pt) ceratoprótese e usos dos mesmos.
BR112017018834A2 (pt) variantes de protoxina-ii e métodos de uso
BR112018002382A2 (pt) novos anticorpos anti-gvpi humano e usos dos mesmos
BR112016007062A2 (pt) variantes de protoxina-ii e métodos de uso
BR112017015159A2 (pt) preparação e uso de produtos plaquetários
BR112017020896A2 (pt) variantes de protoxina-ii e métodos de uso
EP3378294A4 (en) SAFETY DEVICE FOR A GRUBBER
BR112017008707A8 (pt) Ração de pré-mistura para aquacultura encapsulada
IN2014CH00840A (pt)
WO2014152946A3 (en) Polypeptides for treating and/or limiting influenza infection
IL252683A0 (en) Pyridyl-cycloalkyl-substituted carboxylic acids, preparations containing them and their medical uses
TWD181370S (zh) 鎖定鉗
FR3026399B1 (fr) Grue, notamment grue-derrick
MX2015015428A (es) Eliminacion de riesgo de narcolepsia en vacunas contra influenza.
KR20180084962A (ko) 마스터 디스크 및 그 장착 방법과 분리 방법
UY36306A (es) Sintesis de ent-progesterona e intermediarios de la misma
NZ721832A (en) Solid forms of tenofovir

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements